The Hidden Danger of IgAN: Pathogenesis and Unmet Needs
Jonathan Barratt, MD, PhD
Proteinuria in IgAN: The Signal, The Target, and the Treatment Goal
An De Vriese, MD, PhD
The Future of IgAN Care
Chee Kay Cheung, MBChB, MRCP, PhD
Jörg Latus, MD
The Evolving Role of Biomarkers in IgAN
Unmasking IgAN: Achieving Earlier Diagnosis
Decoding IgA Nephropathy: From Suspicion to Solution
Mechanisms Matter! Optimizing Proteinuria Reduction In IgAN
Navigating KDIGO Guidance in IgAN
Translating Evidence into IgAN Care
Engaging Patients With Heart Failure and Chronic Hyperkalemia: Shared Decision-Making to Support Guideline-Directed Medical Therapy
Gianluigi Savarese, MD, PhD, FESC, FHFA
Spotlight on Assessment: Tools That Capture CKD-aP
Federico Alberici, MD, PhD
Anastasia Liossatou, PhD, RN
Frontline Champions: Nurses as Drivers of Symptom-Based CKD-aP Care
When Itching Hurts: Quality of Life Disruption in CKD-aP
Nancy Helou, PhD
Steven Fishbane, MD
Winning the CKD-aP Battle: A United Physician-Nurse Front
What You Don’t See: A Patient’s View of Living with CKD-aP
CKD-aP Uncovered Prevalence & Pathophysiology